- Title
- PD69-01 A PHASE IIA STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF THE SELECTIVE OXYTOCIN RECEPTOR ANTAGONIST, IX-01, IN MEN WITH LIFELONG PREMATURE EJACULATION
- Creators
- Christopher McMahon - Sydney, AustraliaIan Osterloh - Sandwich, United KingdomRaymond Rosen - Boston, MAStanley Althof - Palm Beach NeurologyGary Muirhead - Sandwich, United KingdomBrian Harty - Boston, MAFrancois Giuliano - Garches, FranceMartin Miner - Providence CollegeBronwyn Stuckey - Nedlands, AustraliaMarc Gittelman - Aventura Hospital and Medical CenterLaurence Belkoff - Alliance for Decision EducationWayne Hellstrom - New Orleans, LAAllen Seftel - Camden County CollegeIrwin Goldstein - San Diego, CA
- Publication Details
- The Journal of urology, v 197(4S), e1344
- Publisher
- ELSEVIER SCIENCE INC
- Number of pages
- 1
- Grant note
Ixchelsis Ltd.
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Surgery
- Web of Science ID
- WOS:000398276605416
- Other Identifier
- 991021916798204721
Abstract
PD69-01 A PHASE IIA STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF THE SELECTIVE OXYTOCIN RECEPTOR ANTAGONIST, IX-01, IN MEN WITH LIFELONG PREMATURE EJACULATION
The Journal of urology, v 197(4S), e1344
Apr 2017
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
7 Record Views
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Urology & Nephrology